84 participants
Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-12-21
- Start Date:
- 2015-03-14
- Completion:
- 2019-10-23
Conditions
- Fabry Disease
Interventions
- DRUG